These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 16541466

  • 1. Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice.
    Reilly CM, Olgun S, Goodwin D, Gogal RM, Santo A, Romesburg JW, Ahmed SA, Gilkeson GS.
    Eur J Immunol; 2006 May; 36(5):1296-308. PubMed ID: 16541466
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice.
    Haas C, Ryffel B, Le Hir M.
    J Immunol; 1997 Jun 01; 158(11):5484-91. PubMed ID: 9164971
    [Abstract] [Full Text] [Related]

  • 6. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.
    Lee HJ, Oh YK, Rhee M, Lim JY, Hwang JY, Park YS, Kwon Y, Choi KH, Jo I, Park SI, Gao B, Kim WH.
    J Mol Biol; 2007 Jun 15; 369(4):967-84. PubMed ID: 17475277
    [Abstract] [Full Text] [Related]

  • 7. C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice.
    Wenderfer SE, Ke B, Hollmann TJ, Wetsel RA, Lan HY, Braun MC.
    J Am Soc Nephrol; 2005 Dec 15; 16(12):3572-82. PubMed ID: 16207826
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
    Sadanaga A, Nakashima H, Masutani K, Miyake K, Shimizu S, Igawa T, Sugiyama N, Niiro H, Hirakata H, Harada M.
    Arthritis Rheum; 2005 Dec 15; 52(12):3987-96. PubMed ID: 16320345
    [Abstract] [Full Text] [Related]

  • 10. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.
    Sadanaga A, Nakashima H, Akahoshi M, Masutani K, Miyake K, Igawa T, Sugiyama N, Niiro H, Harada M.
    Arthritis Rheum; 2007 May 15; 56(5):1618-28. PubMed ID: 17469144
    [Abstract] [Full Text] [Related]

  • 11. Inducible co-stimulator null MRL-Faslpr mice: uncoupling of autoantibodies and T cell responses in lupus.
    Zeller GC, Hirahashi J, Schwarting A, Sharpe AH, Kelley VR.
    J Am Soc Nephrol; 2006 Jan 15; 17(1):122-30. PubMed ID: 16291836
    [Abstract] [Full Text] [Related]

  • 12. Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice.
    Tada Y, Nagasawa K, Ho A, Morito F, Koarada S, Ushiyama O, Suzuki N, Ohta A, Mak TW.
    J Immunol; 1999 Sep 15; 163(6):3153-9. PubMed ID: 10477582
    [Abstract] [Full Text] [Related]

  • 13. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlöndorff D, Luckow B.
    J Am Soc Nephrol; 2005 Dec 15; 16(12):3592-601. PubMed ID: 16267157
    [Abstract] [Full Text] [Related]

  • 14. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
    Matsumoto K, Watanabe N, Akikusa B, Kurasawa K, Matsumura R, Saito Y, Iwamoto I, Saito T.
    Arthritis Rheum; 2003 Feb 15; 48(2):486-94. PubMed ID: 12571859
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U.
    J Immunol; 2009 Oct 01; 183(7):4693-704. PubMed ID: 19734217
    [Abstract] [Full Text] [Related]

  • 17. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
    Tada Y, Kondo S, Aoki S, Koarada S, Inoue H, Suematsu R, Ohta A, Mak TW, Nagasawa K.
    Arthritis Rheum; 2011 Mar 01; 63(3):738-48. PubMed ID: 21305501
    [Abstract] [Full Text] [Related]

  • 18. Skin disease is prevented but nephritis is accelerated by multiple pregnancies in autoimmune MRL/LPR mice.
    Kökény G, Godó M, Nagy E, Kardos M, Kotsch K, Casalis P, Bodor C, Rosivall L, Volk HD, Zenclussen AC, Hamar P.
    Lupus; 2007 Mar 01; 16(7):465-77. PubMed ID: 17670844
    [Abstract] [Full Text] [Related]

  • 19. Role of inducible costimulator in the development of lupus in MRL/lpr mice.
    Tada Y, Koarada S, Tomiyoshi Y, Morito F, Mitamura M, Haruta Y, Ohta A, Nagasawa K.
    Clin Immunol; 2006 Aug 01; 120(2):179-88. PubMed ID: 16616645
    [Abstract] [Full Text] [Related]

  • 20. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
    Parietti V, Monneaux F, Décossas M, Muller S.
    Arthritis Rheum; 2008 Jun 01; 58(6):1751-61. PubMed ID: 18512811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.